Cystic Fibrosis
📧 Sign up to get email alerts when something new happens for Cystic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis [Phase 3]
Phase 3 clinical trial comparing inhaled glutathione (GSH) to placebo in cystic fibrosis; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Tobramycin Inhalation Powder (TIP) in Cystic Fibrosis Subjects [Phase 3]
Phase 3 trial of Tobramycin Inhalation Powder for cystic fibrosis was terminated.
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic Fibrosis [Phase 2]
Phase 2 trial investigating a DHA-rich supplement's effect on DHA status and overall health in cystic fibrosis patients has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Efficacy and Safety of 28 or 56 Day Treatment for Pseudomonas Aeruginosa in Children With Cystic Fibrosis [Phase 3]
Phase 3 trial assessing 28-day versus 56-day treatment for Pseudomonas aeruginosa in children with cystic fibrosis; results and safety data …
-
CLINICAL_TRIALS trial_result · 2011-08-29Clinical Trial Update: Cystic Fibrosis and Totally Implantable Vascular Access Devices [Phase 4]
Phase 4 clinical trial evaluating totally implantable vascular access devices in patients with cystic fibrosis and venous thrombosis; study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-24Clinical Trial Update: Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis [NA]
This clinical trial evaluated the tolerability of inhaled hypertonic saline in infants with cystic fibrosis. The study is completed.
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Study About Complications of Totally Implanted Venous Access Devices (TIVADs) in People With Cystic Fibrosis (CF)
A completed clinical trial evaluated complications associated with totally implanted venous access devices (TIVADs) in people with cystic fi…
-
CLINICAL_TRIALS trial_result · 2011-08-23Clinical Trial Update: Evaluation of the Emission Distance of P. Aeruginosa From the Respiratory Tract of People With Cystic Fibrosis
A completed clinical trial from the University of Florence evaluated the distance that Pseudomonas aeruginosa can be emitted from the respir…
-
CLINICAL_TRIALS trial_result · 2011-08-15Clinical Trial Update: The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function [Phase 4]
A Phase 4 trial comparing inhaled N-acetylcysteine to normal saline in cystic fibrosis was terminated; the study aimed to assess sputum rheo…
-
CLINICAL_TRIALS trial_result · 2011-08-10Clinical Trial Update: Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ? [Phase 2]
A Phase 2 trial evaluating nasal instillation of miglustat to normalize nasal potential difference in cystic fibrosis patients has completed…
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa [Phase 1, Phase 2]
A dose-escalation Phase 1/2 trial of KB001 in cystic fibrosis patients infected with Pseudomonas aeruginosa has completed, and results were …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: An Exploratory Study to Assess Multiple Doses of Omalizumab in Patients With Cystic Fibrosis Complicated by Acute Bronchopulmonary Aspergillosis (ABPA) [Phase 4]
Phase 4 exploratory study evaluating multiple doses of omalizumab in cystic fibrosis patients with allergic bronchopulmonary aspergillosis; …
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis [Phase 4]
This Phase 4 trial compares two regimens for eradicating Pseudomonas aeruginosa infection in children with cystic fibrosis and reports updat…
-
CLINICAL_TRIALS approval · 2011-08-02Clinical Trial Update: Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Airway Infection
Aztreonam lysine for inhalation has been approved for use in patients with cystic fibrosis who have Pseudomonas aeruginosa airway infection.…
-
CLINICAL_TRIALS research · 2011-07-22Clinical Trial Update: Standardisation of Measurements in Exhaled Breath and Exhaled Breath Condensate.
A clinical trial update about standardising measurements in exhaled breath and exhaled breath condensate, led by Maastricht University Medic…
-
CLINICAL_TRIALS trial_result · 2011-07-19Clinical Trial Update: Inhaled Sodium Pyruvate for the Treatment of Cystic Fibrosis. [Phase 1]
A Phase 1 trial evaluating inhaled sodium pyruvate for cystic fibrosis has completed.
-
FDA approval · 2011-07-13FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
The FDA approved a supplemental application for Zenpep (pancrelipase) submitted by Aimmune Therapeutics, authorizing changes to labeling rel…
-
FDA approval · 2011-07-12FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for CREON (pancrelipase) from AbbVie Inc., updating its labeling to reflect indications for exoc…
-
CLINICAL_TRIALS trial_result · 2011-07-04Clinical Trial Update: Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa [Phase 3]
Phase 3 trial comparing aztreonam for inhalation solution with tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas a…
-
CLINICAL_TRIALS trial_result · 2011-06-30Clinical Trial Update: Phenylbutyrate/Genistein Duotherapy in Delta F508-Heterozygotes (for Cystic Fibrosis) [Phase 1, Phase 2]
A phase 1/2 trial of phenylbutyrate and genistein duotherapy in Delta F508-heterozygous cystic fibrosis patients was terminated, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis [Phase 4]
Phase 4 clinical trial of Pulmozyme (dornase alfa) in 3- to 5-year-old children with cystic fibrosis was terminated; results were posted in …
-
FDA label_change · 2011-06-15FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)
FDA approved a supplemental application for ZENPEP (pancrelipase) submitted by Aimmune Therapeutics, resulting in changes to the product lab…
-
FDA approval · 2011-06-10FDA Approved: CREON — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for CREON (pancrelipase) from AbbVie.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Choline Nutrition in Children With Cystic Fibrosis (CF) [NA]
A clinical trial evaluating choline nutrition in children with cystic fibrosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption [Phase 2]
Phase 2 trial assessing effectiveness, safety, and palatability of pancrelipase microtablets in infants and toddlers with cystic fibrosis an…